Patents for A61P 33 - Antiparasitic agents (21,787)
09/2011
09/21/2011CN102188655A Molecular Chinese patent medicine for inhibiting defects of Lifei tablets and syndromes of pulmonary tuberculosis
09/21/2011CN102188459A Brucea javanica total terpenoid extractive, and preparation method and application thereof
09/21/2011CN102188435A Compound sulfaclozine sodium suspension and preparation method thereof
09/21/2011CN101084238B Receptor selectivity lymphotoxin derivates
09/20/2011CA2467774C Solubilized topoisomerase poisons
09/20/2011CA2462251C Animal feeds including actives and methods of using same
09/20/2011CA2455966C Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
09/20/2011CA2411726C Use of ingenanes in treating a pkc-related condition or disorder
09/20/2011CA2367149C Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance
09/15/2011WO2011111804A1 Antiprotozoal compound originating in coelenterata
09/15/2011US20110224301 Hmgb1 expression and protective role of semapimod in nec
09/15/2011US20110224289 Compounds of the pterocarpanquinone family, method for preparing the same, pharmaceutical composition containing the new compounds of the pterocarpanquinone family, uses and therapeutic method
09/15/2011US20110224220 Substituted tricyclic derivatives
09/15/2011US20110224210 Novel bis-amides as anti-malarial agents
09/15/2011US20110224162 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity of the inflammatory response
09/15/2011US20110224075 Pesticidal Active Mixtures Comprising Aminothiazoline Compounds
09/15/2011US20110223256 Method For Stabilizing Flavonoid Aqueous Dispersion
09/15/2011US20110223238 Bisbenzamidines for the Treatment of Pneumonia
09/15/2011US20110223195 Composition comprising chitosan for ocular administration of vaccine(s) to avians
09/15/2011US20110223193 Method for the preparation of medical devices and devices obtained therefrom
09/15/2011US20110223189 Agent for treating leishmania infections
09/15/2011US20110223179 Methods and compositions for malaria prophylaxis
09/15/2011US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
09/15/2011US20110220265 Preparation for External Use
09/15/2011CA2792616A1 Parenteral formulations of macrolide antibiotics
09/14/2011EP2365097A1 Nucleic acid probe-based assays for prokaryotic and eukaryotic organisms
09/14/2011EP2364707A2 Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
09/14/2011EP2364301A1 Enantiomerically enriched aryloazol- 2 -yl cyanoethylamino paraciticidal compounds
09/14/2011EP2364147A2 Compositions comprising 1-arylpyrazole alone or in combination with formamidine for the treatment of parasitic infection
09/14/2011EP1237582B1 Methods for introducing genes into mammalian subjects
09/14/2011CN102186845A S1p receptors modulators and their use thereof
09/14/2011CN102186498A Vaccine for treatment/prevention of scuticociliatosis in fish
09/14/2011CN102181450A Trichina Ts27 gene, encoding protein and application thereof
09/14/2011CN102178814A Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof
09/14/2011CN101670062B Chinese herbal compound preparation for treating protozoal disease in animal blood
09/14/2011CN101575327B Antimalarial active isocumarans compound and composition, preparation method and application thereof
09/13/2011US8017589 Avermectin B1 and avermectin B1 monosaccharide derivatives having an alkoxymethyl substituent in the 4″-or 4′-position
09/13/2011CA2670605C Substituted arylpyrazoles
09/09/2011CA2792171A1 Compositions and methods for treating parasitic disease
09/08/2011US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof
09/08/2011US20110218194 Heterocyclic aspartyl protease inhibitors
09/08/2011US20110218179 Treatment of lupus nephritis using laquinimod
09/08/2011US20110218166 Mucoadherents compositions and their use
09/08/2011US20110217366 Immunopotentiating composition
09/08/2011US20110217364 Conjugated suramin amino compounds for medical conditions
09/08/2011US20110217348 Treated textile material for use in aquatic environments
09/08/2011US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds
09/08/2011US20110217244 Compositions and methods for enhancing immune response
09/07/2011EP2362774A1 Anthelmintic compositions
09/07/2011CN1561230B Antigenic compositions
09/07/2011CN102172262A Enzyme treatment for infection
09/07/2011CN101879142B Preparation method of maduramicin ammonium premix
09/07/2011CN101597337B Conjugate of hydroxyalkyl starch and an active agent
09/07/2011CN101348787B Preparation and use of giant panda Ascaris schroederi antigen
09/06/2011US8012996 Methods and composition for inhibition of angiogenesis
09/06/2011US8012985 Compounds with antiparasitic activity and medicines containing same
09/06/2011US8012498 Topical gel formulation comprising organophosphate insecticide and preparation thereof
09/06/2011CA2480552C Amidoacetonitrile compounds and their use as pesticides
09/01/2011WO2011105520A1 Composite body for antigen or drug delivery
09/01/2011WO2011105506A1 Cyclic amine compound and miticide
09/01/2011US20110213029 3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands
09/01/2011US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c
09/01/2011US20110212963 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof
09/01/2011US20110212159 Vaccines
09/01/2011US20110212135 Oligodeoxynucleotide and its use to induce an immune response
09/01/2011US20110212134 Anti-arthropod vector vaccines, methods of selecting and uses thereof
09/01/2011US20110212123 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant
09/01/2011CA2789645A1 Cyclic amine compound and acaricide
08/2011
08/31/2011EP2361920A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity
08/31/2011EP2361055A1 Improved bolus
08/31/2011EP2361053A1 Improvements in bolus devices for the delivery of active agents to animals
08/31/2011EP2006287B1 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient
08/31/2011CN201947851U 一种蜜蜂专用杀蜂螨药片 Dedicated bee bee mites kill pill
08/31/2011CN102168100A Echinococcus granulosusglutathione transferase gene and application thereof
08/31/2011CN102168089A Echinococcus granulosus calreticulin gene and application thereof
08/31/2011CN102167747A Entamoeba histolytica galactose/acetylgalactosamine (Gal/GalNAc) polypeptide fragment, and preparing method and application of polypeptide fragment
08/31/2011CN102167735A Recombinant antigen protein of S.japonicum SjTollip and preparation method and application thereof
08/31/2011CN102166357A Medicinal composition containing bicyclic aza-alkane derivative
08/31/2011CN102166215A Pharmaceutical composition containing piperazine derivatives
08/31/2011CN101940692B Chinese medicinal composition for treating enterovirus syndrome in Dorking and preparation method thereof
08/31/2011CN101289426B Process for preparing restraining agent for leishmaniasis
08/30/2011US8008485 Process for producing 2,3-dihydropyridazine compound
08/30/2011US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
08/30/2011US8008266 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1
08/30/2011US8008078 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
08/25/2011WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011WO2011101367A1 Product for removing sea lice
08/25/2011US20110207784 Oxadiazole-2-oxides as antischistosomal agents
08/25/2011US20110207702 Boron-containing small molecules as anti-protozoal agents
08/25/2011US20110207701 Boron-containing small molecules as antiprotozoal agents
08/25/2011US20110206770 Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns
08/25/2011US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011US20110206728 Dna vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
08/25/2011US20110206714 Malaria vaccine compositions and constituents which elicit cell mediated immunity
08/25/2011US20110206708 Method for stimulating a therapeutic immune effect in a patient
08/25/2011US20110206610 Compositions and methods for enhancing drug delivery across and into epithelial tissues
08/25/2011CA2790176A1 Triazolo [4, 5 - b] pyridin derivatives
08/24/2011EP2360276A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
08/24/2011EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof
08/24/2011EP2360252A1 Immunostimulatory nucleic acid molecules comprising GTCGTT motifs
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 218